MIT’s Biologic program attempts to program living organism and create organically reactive material (Video)

bioLogic is growing living actuators and synthesizing responsive bio-skin in the era where bio is the new interface. We are Imagining a world where actuators and sensors can be grown rather than manufactured, being derived from nature as opposed to engineered in factories. Continue reading “MIT’s Biologic program attempts to program living organism and create organically reactive material (Video)”

“3D Biofabrication of soft tissue : Material challenges” – Presented by Ahmed Aied, Centre for Biomolecular Sciences, University of Nottingham

Three dimensional bioprinting is being applied to tissue engineering and regenerative medicine as a manufacturing tool to produce 3D tissues and organs suitable for transplantation. In the present study, we use micro-extrusion based 3D bioprinting of hydrogels embedded with genetically corrected keratinocytes from recessive dystrophic epidermolysis bullosa (RDEB) to create skin grafts. Continue reading ““3D Biofabrication of soft tissue : Material challenges” – Presented by Ahmed Aied, Centre for Biomolecular Sciences, University of Nottingham”

“Tailored made degradable synthetic polymers for 3D (bio)printing” – Presented by Christian Grandfils, CEIB, University of Liège

Advances in 3D (bio)printing need to have tailored made degradable polymers adapted to build structures mimicking our living structures.

PolyLife, a first spin-off project supported by Wallonia region, and BioMiMedics, an Interreg Meuse-Rhin project, have given us the financial tools to build a reactive extrusion platform allowing to synthesize and process degradable biocompatible polyesters in one single and continuous step. The process is rapid (minute scale), green and the equipment is GMP compliant. Continue reading ““Tailored made degradable synthetic polymers for 3D (bio)printing” – Presented by Christian Grandfils, CEIB, University of Liège”

Léa Pourchet, Université de Lyon, Presents: “Skin equivalent through bioprinting”

The main goal of this work was to print living cells with an open-source printer, part of the new logic of personalized regenerative medicine.

The presented study provides skin equivalent 3D printing proof of concept with strong indicators such as viable cells integration and generation of a 3D network of neo-secretion ECM (Extra-Cellular Matrix), making the printed skin equivalents as close as possible to the real human skin. Continue reading “Léa Pourchet, Université de Lyon, Presents: “Skin equivalent through bioprinting””

3D fab+print is Print and Media Partner of 3D Bioprinting Conference

3D fab+print is a Print and Media Partner of 3D Bioprinting Conference

About 3D fab+print

3D fab+print is a multimedia platform geared to the needs of 3D print and additive manufacturing professionals world-wide. Covering the entire field, from materials to printers and from design software to scanners.

3D fab+print provides the very latest industry news. Regular items include technical updates, product releases, case histories, end user interviews, show/conference overviews, and blogs on the legal implications.

“REGEMAT 3D bioprinting for cartilage regeneration and much more”, Presented by Jose Manuel Baena, REGEMAT 3D

Tissue regeneration (TR) is currently one of the most challenging biotechnology unsolved problems. Tissue engineering (TE) is a multidisciplinary science that aims at solving the problems of TR. TE could solve pathologies and improve the quality of life of billions of people around the world suffering from tissue damages.

New advances in stem cell (SC) research for the regeneration of tissue injuries have opened a new promising research field. However, research carried out nowadays with two-dimensional (2D) cell cultures do not provide the expected results, as 2D cultures do not mimic the 3D structure of a living tissue. Continue reading ““REGEMAT 3D bioprinting for cartilage regeneration and much more”, Presented by Jose Manuel Baena, REGEMAT 3D”

Marcy Zenobi-Wong, ETH Zürich, Presents: “BioPrinting Cartilage”

Bioprinting is an emerging technology for the fabrication of patient-specific, anatomically-complex cartilage organs. Bioinks based on regulatory-compliant polysaccharides are being developed which undergoes cell friendly gelation and yield a strong, ductile material. To make bioinks more tissue-specific and bioactive, micronized extracellular matrix particles can be added. As examples, 3D auricular, nasal, meniscal and vertebral disc grafts based on computer tomography (CT) data or generic 3D models are shown. The bioink supports proliferation and deposition of matrix proteins. This versatile bioprinting method can produce patient-specific cartilage grafts with good mechanical and biological properties. Continue reading “Marcy Zenobi-Wong, ETH Zürich, Presents: “BioPrinting Cartilage””

“Biofabrication: Print your heart out” – Presented by Dirk-Jan Cornelissen, Heriot-Watt University

New drugs can take more than 10 years to develop, and only around 16% of drug candidates that begin pre-clinical testing are approved for human use. This low success rate is partially due to the different responses of humans and the animal models currently used for testing. A key challenge in bioprinting has been the development of more gentle printing processes to preserve cellular functions. By encapsulating cells inside a gel, complex 3D structures can be printed with cells suspended throughout. Continue reading ““Biofabrication: Print your heart out” – Presented by Dirk-Jan Cornelissen, Heriot-Watt University”